Injecting a gene therapy vector into one eye of someone suffering from LHON, the most common cause of mitochondrial blindness, significantly improves vision in both eyes, scientists have found.
From the way we learn, to how our memories are made and stored, the workings of our brains depend on connections forged between billions of neurons, yet much about how our nervous system develops remains a mystery.
A group of researchers from the UK have used inkjet printing technology to successfully print cells taken from the eye for the very first time.
By combining advanced imaging with powerful genetic labelling techniques, Professor Bill Harris has imaged the entire process of retinal development in four dimensions, providing new insights into the enormous complexity of the nervous system.
New treatments for glaucoma are a key priority in vision research. Advances in stem cell technology in Cambridge are helping to make this dream a reality.
The night vision abilities of nocturnal animals such as mice is down to the unconventional way that DNA is packaged within the nuclei of specialised cells responsible for low light vision, say Cambridge University researchers.
A test to show whether a person may be genetically predisposed to suffer one of the most prevalent forms of blindness in the elderly - before symptoms arise - has moved a step closer to reality after a licence agreement involving Cambridge Enterprise.
Pioneering research shines new light on our understanding of the way we see the world. Optical fibres have now been found to exist in vertebrate eyes, channelling light down their length and delivering it without distortion straight to the cells that ‘see’.
© 2025 University of Cambridge